EUR 115.88 For Business Accounts Only

The HIV Vaccine Trials Network - Company Review

The HIV Vaccine Trials Network - Company Review

Summary

The HIV Vaccine Trials Network (HVTN) is a research organization that develops vaccines to prevent HIV/AIDS. The organization implements, designing, and analyzes vaccine trials. Its laboratory center develops an interferon gamma ELISpot assay to measure HIV-specific T cells elicited in HIV vaccine study participants. HVTN conducts clinical trials, evaluating experimental vaccines for safety and immunogenicity and testing vaccine efficacy. The organization also validates an ELISA assay to assess vaccine-induced antibody responses in HIV vaccine study participants. It develops statistical and analytical methods that offer evaluation of HIV vaccine T-cell response profiles. The organization’s network researchers develop various methods of sampling and processing samples from trial participants. HVTN is headquartered in Seattle, Washington, the US.

This comprehensive company report of The HIV Vaccine Trials Network provides you with company's businesses and operations information.

The profile contains critical company information including,

- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.